Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Livermore

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Reviews of Infectious Diseases|July 1, 1988
Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteriaD M Livermore
The Journal of Antimicrobial Chemotherapy|July 1, 1987
'Covalent trapping' and latamoxef resistance in beta-lactamase-derepressed Pseudomonas aeruginosaD M Livermore
The Journal of Antimicrobial Chemotherapy|September 12, 2000
Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?D M Livermore
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Antibiotic uptake and transport by bacteriaD M Livermore
Intensive Care Medicine|April 29, 2000
Epidemiology of antibiotic resistanceD M Livermore
Antimicrobial Agents and Chemotherapy|September 1, 1992
Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosaD M Livermore
The Journal of Antimicrobial Chemotherapy|February 1, 1983
Kinetics and significance of the activity of the Sabath and Abrahams' beta-lactamase of Pseudomonas aeruginosa against cefotaxime and cefsulodinD M Livermore
Intensive Care Medicine|July 1, 1994
Evolution of beta-lactamase inhibitorsD M Livermore
The Journal of Antimicrobial Chemotherapy|May 1, 1985
Do beta-lactamases 'trap' cephalosporins?D M Livermore
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
Defining an extended-spectrum beta-lactamaseD M Livermore
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Reviews of Infectious Diseases|July 1, 1988
Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteriaD M Livermore
The Journal of Antimicrobial Chemotherapy|July 1, 1987
'Covalent trapping' and latamoxef resistance in beta-lactamase-derepressed Pseudomonas aeruginosaD M Livermore
The Journal of Antimicrobial Chemotherapy|September 12, 2000
Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?D M Livermore
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Antibiotic uptake and transport by bacteriaD M Livermore
Intensive Care Medicine|April 29, 2000
Epidemiology of antibiotic resistanceD M Livermore
Antimicrobial Agents and Chemotherapy|September 1, 1992
Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosaD M Livermore
The Journal of Antimicrobial Chemotherapy|February 1, 1983
Kinetics and significance of the activity of the Sabath and Abrahams' beta-lactamase of Pseudomonas aeruginosa against cefotaxime and cefsulodinD M Livermore
Intensive Care Medicine|July 1, 1994
Evolution of beta-lactamase inhibitorsD M Livermore
The Journal of Antimicrobial Chemotherapy|May 1, 1985
Do beta-lactamases 'trap' cephalosporins?D M Livermore
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
Defining an extended-spectrum beta-lactamaseD M Livermore
Pageof 25